Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release Dec 01 2023

· Issued by Zydus Lifesciences Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-dec-01-2023-4

Zydus Lifesciences Limited has informed the Exchange regarding a press release dated December 01, 2023, titled "Zydus receives final approval from the USFDA forIvabradine Tablets, 5 mg and 7.5 mg".

View Attachment

6ix hasn’t read this filing yet.

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases